Post-earnings recap
Reported
Tue, Jul 28, 2026
EPS actual
$-3.32
EPS est.
$-0.02
EPS surprise
-16500.00%
1-day move
+0.02%
Core Scientific reported a significant loss in EPS, which is concerning for investors. However, the stock saw a slight increase of 0.02%, indicating that investors may have had lower expectations or are reacting to other factors. The lack of revenue data and management commentary leaves uncertainty about the company's current situation and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-3.32 | N/A | -16500.00% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results. Therefore, there is no management commentary available.
Core Scientific, Inc. operates in the information technology sector, focusing on application software. The company is significant in the context of emerging technologies, particularly in areas like artificial intelligence and cloud computing, which are driving demand for innovative software solutions.
Last quarter
In the last quarter, Core Scientific reported an EPS of -$1.06, significantly missing expectations. Despite this, the stock saw an 11% increase the following day, indicating some investor optimism.
EPS beat streak
0Q
EPS beat rate
50%
Avg EPS surprise
-2922.33%
Avg 1-day reaction
+3.43%
Overall, expectations are mixed as the company has shown volatility in its earnings history. Investors are keen to see if the company can stabilize its performance after a significant miss last quarter.
Bull case
If Core Scientific can demonstrate strong revenue growth and improve its EPS, it could signal a turnaround, leading to increased investor confidence.
Bear case
Conversely, if the company continues to miss earnings expectations and fails to show meaningful revenue growth, it could lead to further declines in stock price.
The print will turn on these.
Q1
What will the EPS be this quarter, and how does it compare to previous estimates?
Given the company's recent history of significant EPS surprises, this number will be critical in shaping investor sentiment.
Q2
What revenue growth can Core Scientific report this quarter?
Investors will closely monitor revenue growth as a sign of the company's ability to expand and compete in the market.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±3.5%
Why consensus could be wrong
The Street may underestimate Core Scientific's potential for a rebound, as recent technological advancements could lead to improved performance.
Supporting evidence
The stock has shown resilience with an 11% increase following a significant EPS miss last quarter.
Options pricing suggests a higher expected volatility, indicating that traders are anticipating a significant move.
The company's historical performance shows a tendency to rebound after misses, with a 50% EPS beat rate.
Key risk
If the company reports an EPS better than -$1.00, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as the company seeks to recover from last quarter's significant earnings miss.
Bull confirmed if
A revenue growth rate of over 15% compared to the previous quarter would confirm the bull case.
Bear confirmed if
If the EPS comes in worse than -$1.00, it would confirm the bear case.
What the market is pricing for the move.
Implied Move
±5.47%
Historical Avg
±4.4%
The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.
Options are pricing ±5.5% while CORZ has averaged ±4.4% over the last 8 prints — setup is pricing rich.
ATM IV
0.9%
30d HV
62.2%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$0.00
0 sh
0 insiders
Sold
$330,642.00
20,000 sh
1 insider
Net
$330,642.00
Net selling
Most Active Insiders· 2 open-market trades
$330,642.00
Net selling
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Core Scientific beats expectations, history suggests the stock could rise by around 0.92%, confirming a positive outlook.
In line / cautious
If results are in line but cautious, the stock may remain stable or see a slight decline as investors digest the information.
Miss
Should the company miss expectations again, history suggests a potential decline of about 6.21%, indicating ongoing investor concern.
The lines on the call that would change the story.
Recent Transactions
Sep 28, 2026 · @ $16.76
10,000 sh
$167,586.00
Oct 5, 2026 · @ $16.31
10,000 sh
$163,056.00
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.